John Puisis
Advertisement
John Puisis is a consultant with Spencer Stuart, an investment advisor specializing in biotech and pharmaceutical companies, based in Chicago.
Articles by John Puisis
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta
3
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
4
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
5